Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in Japan

Shinichi Sugiura, Hirokazu Nakanishi, Mika Asano, Tohru Hashida, Manabu Tanimura, Toshihiro Hama, Toshitaka Nabeshima

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Purpose. A multicenter field survey of environmental contamination and exposure of healthcare professionals to anticancer drugs were performed. Setting. Three university hospitals, one cancer specialty hospital and two corporate hospitals from across Japan. Method. The environmental contamination with cyclophosphamide (CP) was investigated. A wipe examination was performed at six sites apiece in two divisions. The urinary excretion of the CP over 24 h was determined. The subjects of the survey included physicians, pharmacists, and nurses, for a total of seven at each facility irrespective of job title. The wipe samples were collected at 12 sites within two divisions at each facility. For the exposure survey, the total urine volume was determined, and a portion of the urine sample was then collected from each participants at each facility. Urine was collected for 24 h. The samples were determined by using the GC-MS method. Results. Wipe examination: contamination with CP was identified at 50% of the sites. The concentration was high (CP > 1.00 ng/cm 2) in the general environment in two hospitals and in the safety cabinet in one hospital. In the survey for the exposure of staff to anticancer drugs, 276 samples were obtained from 41 healthcare professionals. CP was detected in 90 samples obtained from 23 subjects. The amount of exposure was greatly different among the facilities. The urinary excretion of CP per subject was between 2.7 and 462.8 ng/24 h. The range of urinary excretion for each hospital was between 4.6 and 211.2 ng/24 h.

Original languageEnglish
Pages (from-to)20-28
Number of pages9
JournalJournal of Oncology Pharmacy Practice
Volume17
Issue number1
DOIs
Publication statusPublished - 01-03-2011

Fingerprint

Environmental Monitoring
Occupational Exposure
Cyclophosphamide
Multicenter Studies
Japan
Urine
Delivery of Health Care
Cancer Care Facilities
Environmental Exposure
Pharmacists
Pharmaceutical Preparations
Nurses
Physicians
Safety
Surveys and Questionnaires

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology (medical)

Cite this

Sugiura, Shinichi ; Nakanishi, Hirokazu ; Asano, Mika ; Hashida, Tohru ; Tanimura, Manabu ; Hama, Toshihiro ; Nabeshima, Toshitaka. / Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in Japan. In: Journal of Oncology Pharmacy Practice. 2011 ; Vol. 17, No. 1. pp. 20-28.
@article{e3766a8277794492b5e063cd0dd8f51b,
title = "Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in Japan",
abstract = "Purpose. A multicenter field survey of environmental contamination and exposure of healthcare professionals to anticancer drugs were performed. Setting. Three university hospitals, one cancer specialty hospital and two corporate hospitals from across Japan. Method. The environmental contamination with cyclophosphamide (CP) was investigated. A wipe examination was performed at six sites apiece in two divisions. The urinary excretion of the CP over 24 h was determined. The subjects of the survey included physicians, pharmacists, and nurses, for a total of seven at each facility irrespective of job title. The wipe samples were collected at 12 sites within two divisions at each facility. For the exposure survey, the total urine volume was determined, and a portion of the urine sample was then collected from each participants at each facility. Urine was collected for 24 h. The samples were determined by using the GC-MS method. Results. Wipe examination: contamination with CP was identified at 50{\%} of the sites. The concentration was high (CP > 1.00 ng/cm 2) in the general environment in two hospitals and in the safety cabinet in one hospital. In the survey for the exposure of staff to anticancer drugs, 276 samples were obtained from 41 healthcare professionals. CP was detected in 90 samples obtained from 23 subjects. The amount of exposure was greatly different among the facilities. The urinary excretion of CP per subject was between 2.7 and 462.8 ng/24 h. The range of urinary excretion for each hospital was between 4.6 and 211.2 ng/24 h.",
author = "Shinichi Sugiura and Hirokazu Nakanishi and Mika Asano and Tohru Hashida and Manabu Tanimura and Toshihiro Hama and Toshitaka Nabeshima",
year = "2011",
month = "3",
day = "1",
doi = "10.1177/1078155210369851",
language = "English",
volume = "17",
pages = "20--28",
journal = "Journal of Oncology Pharmacy Practice",
issn = "1078-1552",
publisher = "SAGE Publications Ltd",
number = "1",

}

Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in Japan. / Sugiura, Shinichi; Nakanishi, Hirokazu; Asano, Mika; Hashida, Tohru; Tanimura, Manabu; Hama, Toshihiro; Nabeshima, Toshitaka.

In: Journal of Oncology Pharmacy Practice, Vol. 17, No. 1, 01.03.2011, p. 20-28.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in Japan

AU - Sugiura, Shinichi

AU - Nakanishi, Hirokazu

AU - Asano, Mika

AU - Hashida, Tohru

AU - Tanimura, Manabu

AU - Hama, Toshihiro

AU - Nabeshima, Toshitaka

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Purpose. A multicenter field survey of environmental contamination and exposure of healthcare professionals to anticancer drugs were performed. Setting. Three university hospitals, one cancer specialty hospital and two corporate hospitals from across Japan. Method. The environmental contamination with cyclophosphamide (CP) was investigated. A wipe examination was performed at six sites apiece in two divisions. The urinary excretion of the CP over 24 h was determined. The subjects of the survey included physicians, pharmacists, and nurses, for a total of seven at each facility irrespective of job title. The wipe samples were collected at 12 sites within two divisions at each facility. For the exposure survey, the total urine volume was determined, and a portion of the urine sample was then collected from each participants at each facility. Urine was collected for 24 h. The samples were determined by using the GC-MS method. Results. Wipe examination: contamination with CP was identified at 50% of the sites. The concentration was high (CP > 1.00 ng/cm 2) in the general environment in two hospitals and in the safety cabinet in one hospital. In the survey for the exposure of staff to anticancer drugs, 276 samples were obtained from 41 healthcare professionals. CP was detected in 90 samples obtained from 23 subjects. The amount of exposure was greatly different among the facilities. The urinary excretion of CP per subject was between 2.7 and 462.8 ng/24 h. The range of urinary excretion for each hospital was between 4.6 and 211.2 ng/24 h.

AB - Purpose. A multicenter field survey of environmental contamination and exposure of healthcare professionals to anticancer drugs were performed. Setting. Three university hospitals, one cancer specialty hospital and two corporate hospitals from across Japan. Method. The environmental contamination with cyclophosphamide (CP) was investigated. A wipe examination was performed at six sites apiece in two divisions. The urinary excretion of the CP over 24 h was determined. The subjects of the survey included physicians, pharmacists, and nurses, for a total of seven at each facility irrespective of job title. The wipe samples were collected at 12 sites within two divisions at each facility. For the exposure survey, the total urine volume was determined, and a portion of the urine sample was then collected from each participants at each facility. Urine was collected for 24 h. The samples were determined by using the GC-MS method. Results. Wipe examination: contamination with CP was identified at 50% of the sites. The concentration was high (CP > 1.00 ng/cm 2) in the general environment in two hospitals and in the safety cabinet in one hospital. In the survey for the exposure of staff to anticancer drugs, 276 samples were obtained from 41 healthcare professionals. CP was detected in 90 samples obtained from 23 subjects. The amount of exposure was greatly different among the facilities. The urinary excretion of CP per subject was between 2.7 and 462.8 ng/24 h. The range of urinary excretion for each hospital was between 4.6 and 211.2 ng/24 h.

UR - http://www.scopus.com/inward/record.url?scp=79952403641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952403641&partnerID=8YFLogxK

U2 - 10.1177/1078155210369851

DO - 10.1177/1078155210369851

M3 - Article

C2 - 20472603

AN - SCOPUS:79952403641

VL - 17

SP - 20

EP - 28

JO - Journal of Oncology Pharmacy Practice

JF - Journal of Oncology Pharmacy Practice

SN - 1078-1552

IS - 1

ER -